About me

My academic background is a mix of chemical and materials engineering with a focus on their biomedical applications. In particular, my research explores upconversion nanoparticles as a tool for near-infrared triggered drug delivery for applications ranging from chronotherapy (giving chemotherapy at specific times in a cell cycle) for glioblastoma multiforme (GBM) to improving in-vitro fertilization (IVF) outcomes.

I am most interested, however, in maximizing the translational potential of biomedical discoveries via creative knowledge translation strategies, community building between scientists and clinicians, as well as novel educational initiatives.

During my PhD at McGill, I collaborated extensively with fundamental physics research labs at the Institut national de la recherche scientifique (INRS), chemical synthesis and materials science labs at the Université de Montréal (Udem) and McGill, as well as biological cell culture labs at the Research Institute of the McGill University Health Centre (RI-MUHC).

This allowed me to work the full span of the research pipeline, all the way from nanoparticle design and synthesis to characterization using infrared spectroscopy techniques and electron microscopy to testing in in vitro cell culture and in vivo rat models.

With my thesis now submitted, I am on the brink of discovering what’s next for me, so please reach out if you think we could work together in the future!

Educational Background

• BSc in Chemical and Biological Engineering, Princeton University
  • Certificates in Neuroscience and Engineering Biology
  • Elected to Sigma Xi Research Society
• PhD in Materials Engineering, McGill University
  • Vanier Canada Graduate Scholarship
  • Michael Smith Foreign Study Supplement
  • Mitacs Globalink Award
  • Winner of Learner and Faculty Awards for Teaching Innovation 2023
  • Vasdasz Doctoral Fellowship in Engineering
  • Masters to PhD Fast Track Award
  • McGill Engineering Doctoral Award (MEDA)

Other Educational Qualifications

• Leader of Tomorrow 2020, Global Biotech Revolution
  • Named one of 100 Leaders of Tomorrow in the global biotechnology industry, a distinction given to young scientists & entrepreneurs from over 50 nations (out of 600 applicants)
• Graduate of CANTRAIN Career Development Program
  • Selected as one of 25 students across Canada to be part of a training program on clinical trial operations, medical affairs and regulatory affairs.
  • Completed training in ICH-GCP, Health Canada Part C Regulations and TCPS2 Human Ethics.